Streetbeat News

Equity Actions

MIST

Milestone Pharmaceuticals has announced a proposed public offering of common shares and pre-funded warrants. This move is aimed at raising capital, potentially for further research, development, and operational activities. The specifics of the offering, such as pricing and the number of shares or warrants, were not disclosed in the announcement.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:51 pm

DMRC

Digimarc Corporation (NASDAQ:DMRC) has raised $32.5 million through the sale of 928,571 shares to a group led by Altai Capital, its second largest shareholder. This capital raise includes both new and existing investors and is aimed at accelerating Digimarc's growth in digital watermarking technologies. Altai Capital has been increasing its investment in Digimarc since 2021, highlighting the company's strong market position and expanding opportunities.

Portfolio Pulse from Happy Mohamed

February 28, 2024 | 9:47 pm

FBMS

The First Bancshares has announced a new share repurchase plan, authorizing the repurchase of up to $50 million of its shares. This move is aimed at enhancing shareholder value and reflects the company's confidence in its financial health and future prospects.

Portfolio Pulse from Charles Gross

February 28, 2024 | 9:45 pm

XPER

Xperi has announced the initiation of a formal process to evaluate strategic alternatives for its Perceive business, aiming to enhance shareholder value. This could include a range of options such as a sale, merger, or other business combinations.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:38 pm

WW

WW International shares dropped following the announcement of Q4 financial results and news that Oprah Winfrey will not seek re-election as a director at the upcoming annual shareholders meeting.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:36 pm

OKTA

Okta, Inc. (NASDAQ:OKTA) announced new executive appointments to strengthen its go-to-market team and drive growth. Eric Kelleher is promoted to President, Customer Experience & Communications, Ed Daly to Chief Customer Officer, and Christine Halvorsen joins as CTO, Public Sector. These moves underscore Okta's commitment to customer engagement and innovation, following the company's growth to over $2 billion in revenue and nearly 19,000 customers. The appointments aim to enhance customer experiences, brand loyalty, and identity security solutions.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:36 pm

ADMA

ADMA Biologics announced that Brian Lenz, the Executive Vice President, CFO, and General Manager of ADMA BioCenters, will transition to a consulting role starting April 1, 2024. Grossman has been appointed as the Interim Chief Financial Officer from the same date, while the company searches for a full-time CFO replacement.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:27 pm

CRM

Salesforce has announced an increase in its share repurchase authorization by $10 billion, signaling confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:23 pm

WW

Oprah Winfrey, a director at WW International, will not seek re-election at the May 2024 shareholders meeting. She plans to donate all her WW stock to the NMAAHC in March 2024, a move supported by the WW Board of Directors.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:04 pm

CLDX

Celldex Therapeutics has announced its intention to offer and sell $250 million worth of shares of its common stock through a public offering. All shares in this offering are being sold directly by the company.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:02 pm